|
|
 |
|
Viewing report
|
|
|
|
Ulcerative Colitis – Executive Market Summary 2011
Timely Data Resources, Inc., June 2011, Pages: 15
The Ulcerative Colitis Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence prevalence information for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the ulcerative colitis market, as well as sales of leading drugs and therapies are provided.
Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Executive Market Summary provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.
The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Customers who bought this item also bought
Disease and Therapy Review: Angina Pectoris
Disease and Therapy Review: Attention Deficit Hyperactivity Disorder (ADHD)
Disease and Therapy Review: Myocardial Infarction
Disease and Therapy Review: Generalized Anxiety Disorder (GAD)
Onychomycosis – Executive Market Summary 2011
Disease and Therapy Review: Diabetes
Global Ulcerative Colitis Drug Pipeline Capsule - 2012
Gastrointestinal Disorder Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets
Ulcerative Colitis: KOL Insights on Treatment Practices and Unmet Needs
Inflammatory Bowel Disease Therapeutics - Global Strategic Business Report
|
|
|
|
